Yi Chen
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Organic Chemistry top 5%
- Synthesis and biological activity
Papers in
-
- Histone Deacetylase Inhibitors Research 11
- Cancer therapeutics and mechanisms 10
- Epigenetics and DNA Methylation 5
- Oncology 18
- PARP inhibition in cancer therapy 9
- Co-authors
- Jian Ding (55 shared papers)Jian Ping Ding (2 shared papers)Meiyu Geng (26 shared papers)Yafang Wang (2 shared papers)Yu Lei (2 shared papers)Wei Ping Lu (15 shared papers)Yanyan Shen (12 shared papers)Ze‐Hong Miao (11 shared papers)
- Journals
- Acta Pharmacologica Sinica (15 papers)European Journal of Medicinal Chemistry (11 papers)Journal of Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (7 papers)Bioorganic & Medicinal Chemistry (6 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yi Chen
129 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 130
- Oncology 657
- Organic Chemistry 663
- Molecular Biology 1.2k
- Cancer Research 245
- Biomaterials 202
Countries citing papers authored by Yi Chen
This map shows the geographic impact of Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Chen more than expected).
Fields of papers citing papers by Yi Chen
This network shows the impact of papers produced by Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Chen. The network helps show where Yi Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 246 | |
| 2 | 2019 | 155 | |
| 3 | 2016 | 145 | |
| 4 | 2020 | 117 | |
| 5 | 2015 | 113 | |
| 6 | 2011 | 106 | |
| 7 | 2021 | 100 | |
| 8 | 2006 | 99 | |
| 9 | 2016 | 90 | |
| 10 | 2017 | 90 | |
| 11 | 2013 | 82 | |
| 12 | 2006 | 79 | |
| 13 | 2015 | 76 | |
| 14 | 2015 | 73 | |
| 15 | 2013 | 64 | |
| 16 | 2018 | 62 | |
| 17 | 2009 | 60 | |
| 18 | 2016 | 60 | |
| 19 | 2016 | 59 | |
| 20 | 2023 | 59 |
About Yi Chen
Yi Chen is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 134 papers that have together received 3.9k indexed citations. Recurring topics across this work include Synthesis and biological activity (18 papers), Lung Cancer Treatments and Mutations (12 papers), Histone Deacetylase Inhibitors Research (11 papers), Cancer therapeutics and mechanisms (10 papers), PARP inhibition in cancer therapy (9 papers), Cancer Mechanisms and Therapy (8 papers), Nanoparticle-Based Drug Delivery (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Oncology (657 citations), Organic Chemistry (663 citations), Molecular Biology (1.2k citations), Cancer Research (245 citations) and Biomaterials (202 citations). Yi Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jian Ding, Jian Ping Ding, Meiyu Geng, Yafang Wang, Yu Lei, Wei Ping Lu, Yanyan Shen, Ze‐Hong Miao, Qin Xie and Linjiang Tong. Their work appears in journals such as Acta Pharmacologica Sinica, European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.